JPS5742651A - Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same - Google Patents
Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing sameInfo
- Publication number
- JPS5742651A JPS5742651A JP11151481A JP11151481A JPS5742651A JP S5742651 A JPS5742651 A JP S5742651A JP 11151481 A JP11151481 A JP 11151481A JP 11151481 A JP11151481 A JP 11151481A JP S5742651 A JPS5742651 A JP S5742651A
- Authority
- JP
- Japan
- Prior art keywords
- manufacture
- hydroxybutyric acid
- drug containing
- containing same
- hygroscopic salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3027390 | 1980-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5742651A true JPS5742651A (en) | 1982-03-10 |
Family
ID=6107582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11151481A Pending JPS5742651A (en) | 1980-07-17 | 1981-07-16 | Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS5742651A (en) |
ZA (1) | ZA814854B (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54131665A (en) * | 1978-04-04 | 1979-10-12 | Chugai Shashin Yakuhin | Production of porous resin |
JP2005532362A (en) * | 2002-06-13 | 2005-10-27 | ノバルティス アクチエンゲゼルシャフト | Calcium salt of indole-derived statin |
JP2007195729A (en) * | 2006-01-26 | 2007-08-09 | Ntt Facilities Inc | Furniture for storage |
US7851506B2 (en) | 1998-12-23 | 2010-12-14 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
JP2014513046A (en) * | 2011-02-14 | 2014-05-29 | コンサート ファーマシューティカルズ インコーポレイテッド | Deuterated analog of 4-hydroxybutyric acid |
US8771735B2 (en) | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
US10532971B2 (en) | 2009-04-23 | 2020-01-14 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
US10758488B2 (en) | 2010-03-24 | 2020-09-01 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US11400052B2 (en) | 2018-11-19 | 2022-08-02 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
US11426373B2 (en) | 2017-03-17 | 2022-08-30 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11839597B2 (en) | 2016-07-22 | 2023-12-12 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US12097175B2 (en) | 2023-09-14 | 2024-09-24 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
-
1981
- 1981-07-15 ZA ZA814854A patent/ZA814854B/en unknown
- 1981-07-16 JP JP11151481A patent/JPS5742651A/en active Pending
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54131665A (en) * | 1978-04-04 | 1979-10-12 | Chugai Shashin Yakuhin | Production of porous resin |
JPS6136535B2 (en) * | 1978-04-04 | 1986-08-19 | Chugai Shashin Yakuhin Kk | |
US8859619B2 (en) | 1998-12-23 | 2014-10-14 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US9539330B2 (en) | 1998-12-23 | 2017-01-10 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US7851506B2 (en) | 1998-12-23 | 2010-12-14 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US8263650B2 (en) | 1998-12-23 | 2012-09-11 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US8324275B2 (en) | 1998-12-23 | 2012-12-04 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US8461203B2 (en) | 1998-12-23 | 2013-06-11 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
US8952062B2 (en) | 1998-12-23 | 2015-02-10 | Jazz Pharmaceuticals, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
JP2005532362A (en) * | 2002-06-13 | 2005-10-27 | ノバルティス アクチエンゲゼルシャフト | Calcium salt of indole-derived statin |
JP2007195729A (en) * | 2006-01-26 | 2007-08-09 | Ntt Facilities Inc | Furniture for storage |
US8771735B2 (en) | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
US9795567B2 (en) | 2008-11-04 | 2017-10-24 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
US11161798B2 (en) | 2009-04-23 | 2021-11-02 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
US11939285B2 (en) | 2009-04-23 | 2024-03-26 | Sun Pharmaceutical Industries, Inc. | 4-hydroxybutyric acid analogs |
US10532971B2 (en) | 2009-04-23 | 2020-01-14 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
US10813885B1 (en) | 2010-03-24 | 2020-10-27 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US10959956B2 (en) | 2010-03-24 | 2021-03-30 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US11207270B2 (en) | 2010-03-24 | 2021-12-28 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US11090269B1 (en) | 2010-03-24 | 2021-08-17 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US10987310B2 (en) | 2010-03-24 | 2021-04-27 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US10966931B2 (en) | 2010-03-24 | 2021-04-06 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US10758488B2 (en) | 2010-03-24 | 2020-09-01 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
JP2017165747A (en) * | 2011-02-14 | 2017-09-21 | コンサート ファーマシューティカルズ インコーポレイテッド | 4-hydroxybutyric acid deuterated analogs |
JP2014513046A (en) * | 2011-02-14 | 2014-05-29 | コンサート ファーマシューティカルズ インコーポレイテッド | Deuterated analog of 4-hydroxybutyric acid |
US8901173B2 (en) | 2012-12-14 | 2014-12-02 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US9555017B2 (en) | 2012-12-14 | 2017-01-31 | Jazz Pharmaceuticals Ireland Limited | Methods of making a mixture of salts of gamma-hydroxybutyrate |
US10675258B2 (en) | 2012-12-14 | 2020-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of using gamma-hydroxybutyrate compositions for the treatment of disorders |
US9132107B2 (en) | 2012-12-14 | 2015-09-15 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US10195168B2 (en) | 2012-12-14 | 2019-02-05 | Jazz Pharmaceuticlas Ireland Limited | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders |
JP2016503762A (en) * | 2012-12-14 | 2016-02-08 | ジャズ ファーマシューティカルス アイルランド リミテッド | Gamma-hydroxybutyrate composition and its use for the treatment of disease |
US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US11554102B2 (en) | 2012-12-14 | 2023-01-17 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders |
US11077079B1 (en) | 2015-02-18 | 2021-08-03 | Jazz Pharmaceuticals Ireland Limited | GHB formulation and method for its manufacture |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
US11147782B1 (en) | 2015-02-18 | 2021-10-19 | Jazz Pharmaceuticals Ireland Limited | GHB formulation and method for its manufacture |
US11364215B1 (en) | 2015-02-18 | 2022-06-21 | Jazz Pharmaceuticals Ireland Limited | GHB formulation and method for its manufacture |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11896572B2 (en) | 2016-07-22 | 2024-02-13 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11839597B2 (en) | 2016-07-22 | 2023-12-12 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11766418B2 (en) | 2016-07-22 | 2023-09-26 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11826335B2 (en) | 2016-07-22 | 2023-11-28 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11426373B2 (en) | 2017-03-17 | 2022-08-30 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US11400052B2 (en) | 2018-11-19 | 2022-08-02 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US12097175B2 (en) | 2023-09-14 | 2024-09-24 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US12097176B2 (en) | 2023-11-10 | 2024-09-24 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Also Published As
Publication number | Publication date |
---|---|
ZA814854B (en) | 1982-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5742651A (en) | Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same | |
DE3171354D1 (en) | Imidazolylpropanol compounds and their acid addition salts, and production and use thereof | |
NZ198106A (en) | Pharmaceutical powder containing microencapsulated bacampicillin acid addition salt | |
JPS57159772A (en) | 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them | |
JPS5798281A (en) | Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same | |
JPS57144219A (en) | Azobissalicylic acid and salts thereof and medicinal composition containing them | |
IL62960A (en) | Imidazoazolepropenoic acid amides,their production and pharmaceutical compositions containing them | |
JPS56154417A (en) | Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it | |
IL62912A0 (en) | Penam-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
ZA812672B (en) | Use as medicaments of substituted derivatives of 4-phenyl-4-oxo-2-butenoic acid | |
JPS57183736A (en) | Novel derivative of phenylaliphatic carboxylic acid, manufacture, use as drug and composition containing same | |
IL75322A (en) | Herbicide antidotes containing benzoxazolyl-and benzothiazolyl-amino acid derivatives,some novel compounds of this type and process for their preparation | |
JPS5681569A (en) | Salt of dihaloo22quinoxalinecarboxylic acid | |
JPS5672020A (en) | Manufacture of polyamine acid | |
JPS57123197A (en) | Manufacture of 1-aminoalkane-1,1-diphosphoric acid | |
JPS57181057A (en) | Manufacture of 4-amino-3,5,6-trichloropicolinic acid | |
PH17057A (en) | Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same | |
DE3175699D1 (en) | Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4h-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions | |
GB2036748B (en) | Silver salts of phosphanilic acid | |
JPS57108059A (en) | Manufacture of 1,4-diamino-anthraquinone-2- sulfonic acid | |
IL69858A (en) | 2-phenoxypropionic acid derivatives of pentites,processes for their preparation and herbicidal compositions containing them | |
IL62326A0 (en) | 7 beta-amido-3-cephem-4-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS568362A (en) | Manufacture of 55aroyll11lower alkylpyrrolee 22acetic acid salt | |
JPS56140968A (en) | Manufacture of carbamoylsulfonic acid derivative salt | |
JPS57159780A (en) | 1-oxide nicotic acid thioalkylamide, salt thereof, manufacture and pharmaceucological composition |